Tenaya Therapeutics, Inc. Insider Trading
TNYA
Insiders sold 45K and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Mar 2025.
Get an email when TNYA's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 17 | Faraz Ali Chief Executive Officer | SoldNo plan | 3,499 | $0.32 | 1K | 0.6% | Form 4 |
| Nov 17 | Whittemore Tingley Chief Medical Officer | SoldNo plan | 3,223 | $0.32 | 1K | 1.2% | Form 4 |
| Aug 17 | Faraz Ali Chief Executive Officer | SoldNo plan 4 parts | 22,232 | $0.71 average | 16K | 5.1% | Form 4 |
| Aug 17 | Whittemore Tingley Chief Medical Officer | SoldNo plan 4 parts | 7,424 | $0.71 average | 5K | 3.4% | Form 4 |
| May 18 | Faraz Ali Chief Executive Officer | SoldNo plan | 3,390 | $0.79 | 3K | 0.8% | Form 4 |
| May 18 | Whittemore Tingley Chief Medical Officer | SoldNo plan | 3,121 | $0.79 | 2K | 1.4% | Form 4 |
| May 18 | Tomohiro Higa SVP, Finance | SoldNo plan | 1,485 | $0.79 | 1K | 1.2% | Form 4 |
| Feb 24 – 25 | TCG Opportunity III GP, LLC Large holder | SoldNo plan 4 parts | 4,170,266 | $0.57 average | $2.37M | 100% | Form 4 |
| Feb 20 – 23 | Column Group Iii-A, LP Large holder | SoldNo plan 4 parts | 829,734 | $0.61 average | 503K | 27% | Form 4 |
| Feb 17 | Tomohiro Higa SVP, Finance | SoldNo plan 3 parts | 3,469 | $0.64 average | 2K | 2.8% | Form 4 |
| Feb 17 | Faraz Ali Chief Executive Officer | SoldNo plan 3 parts | 14,862 | $0.64 average | 10K | 3.2% | Form 4 |
| Feb 17 | Whittemore Tingley Chief Medical Officer | SoldNo plan 3 parts | 5,160 | $0.64 average | 3K | 2.3% | Form 4 |
| Feb 10 – 11 | Column Group Iii-A, LP Large holder | SoldNo plan 4 parts | 4,400,290 | $0.69 average | $3.04M | 62% | Form 4 |
| Nov 17, 2025 | Tomohiro Higa SVP, Finance | SoldNo plan | 1,367 | $1.33 | 2K | 1.4% | Form 4 |
| Nov 17, 2025 | Whittemore Tingley Chief Medical Officer | SoldNo plan | 2,877 | $1.33 | 4K | 1.7% | Form 4 |
| Nov 17, 2025 | Faraz Ali Chief Executive Officer | SoldNo plan | 3,126 | $1.33 | 4K | 1.0% | Form 4 |
| Aug 18, 2025 | Whittemore Tingley Chief Medical Officer | SoldNo plan 3 parts | 5,053 | $1.25 average | 6K | 2.8% | Form 4 |
| Aug 18, 2025 | Faraz Ali Chief Executive Officer | SoldNo plan 3 parts | 14,533 | $1.25 average | 18K | 4.6% | Form 4 |
| Aug 18, 2025 | Tomohiro Higa SVP, Finance | SoldNo plan 3 parts | 2,962 | $1.25 average | 4K | 3.0% | Form 4 |
| May 16, 2025 | Tomohiro Higa SVP, Finance | SoldNo plan | 1,390 | $0.44 | $612 | 1.4% | Form 4 |
| May 16, 2025 | Whittemore Tingley Chief Medical Officer | SoldNo plan | 2,937 | $0.44 | 1K | 1.7% | Form 4 |
| May 16, 2025 | Faraz Ali Chief Executive Officer | SoldNo plan | 3,189 | $0.44 | 1K | 1.0% | Form 4 |
| Mar 10, 2025 | Tomohiro Higa SVP, Finance | SoldNo plan 3 parts | 2,482 | $0.54 average | 1K | 2.4% | Form 4 |
| Mar 10, 2025 | Whittemore Tingley Chief Medical Officer | SoldNo plan 3 parts | 7,398 | $0.54 average | 4K | 4.1% | Form 4 |
| Mar 10, 2025 | Faraz Ali Chief Executive Officer | SoldNo plan 2 parts | 9,741 | $0.54 average | 5K | 2.9% | Form 4 |
| Mar 5, 2025 | Column Group Iii, LP Large holder | Bought | 35,714,284 | $0.70 | $25M | 263% | Form 4 |
| Mar 5, 2025 | David V Goeddel Director | Bought | 35,714,284 | $0.70 | $25M | 263% | Form 4 |
- Nov 17No planFaraz AliChief Executive Officer · sold 3,499 at $0.321K0.6% of stake
- Nov 17No planWhittemore TingleyChief Medical Officer · sold 3,223 at $0.321K1.2% of stake
- Aug 17No planFaraz AliChief Executive Officer · sold 22,232 at avg $0.7116K5.1% of stake
- Aug 17No planWhittemore TingleyChief Medical Officer · sold 7,424 at avg $0.715K3.4% of stake
- May 18No planFaraz AliChief Executive Officer · sold 3,390 at $0.793K0.8% of stake
- May 18No planWhittemore TingleyChief Medical Officer · sold 3,121 at $0.792K1.4% of stake
- May 18No planTomohiro HigaSVP, Finance · sold 1,485 at $0.791K1.2% of stake
- Feb 24 – 25No planTCG Opportunity III GP, LLCLarge holder · sold 4,170,266 at avg $0.57$2.37M100% of stake
- Feb 20 – 23No planColumn Group Iii-A, LPLarge holder · sold 829,734 at avg $0.61503K27% of stake
- Feb 17No planTomohiro HigaSVP, Finance · sold 3,469 at avg $0.642K2.8% of stake
- Feb 17No planFaraz AliChief Executive Officer · sold 14,862 at avg $0.6410K3.2% of stake
- Feb 17No planWhittemore TingleyChief Medical Officer · sold 5,160 at avg $0.643K2.3% of stake
- Feb 10 – 11No planColumn Group Iii-A, LPLarge holder · sold 4,400,290 at avg $0.69$3.04M62% of stake
- Nov 17, 2025No planTomohiro HigaSVP, Finance · sold 1,367 at $1.332K1.4% of stake
- Nov 17, 2025No planWhittemore TingleyChief Medical Officer · sold 2,877 at $1.334K1.7% of stake
- Nov 17, 2025No planFaraz AliChief Executive Officer · sold 3,126 at $1.334K1.0% of stake
- Aug 18, 2025No planWhittemore TingleyChief Medical Officer · sold 5,053 at avg $1.256K2.8% of stake
- Aug 18, 2025No planFaraz AliChief Executive Officer · sold 14,533 at avg $1.2518K4.6% of stake
- Aug 18, 2025No planTomohiro HigaSVP, Finance · sold 2,962 at avg $1.254K3.0% of stake
- May 16, 2025No planTomohiro HigaSVP, Finance · sold 1,390 at $0.44$6121.4% of stake
- May 16, 2025No planWhittemore TingleyChief Medical Officer · sold 2,937 at $0.441K1.7% of stake
- May 16, 2025No planFaraz AliChief Executive Officer · sold 3,189 at $0.441K1.0% of stake
- Mar 10, 2025No planTomohiro HigaSVP, Finance · sold 2,482 at avg $0.541K2.4% of stake
- Mar 10, 2025No planWhittemore TingleyChief Medical Officer · sold 7,398 at avg $0.544K4.1% of stake
- Mar 10, 2025No planFaraz AliChief Executive Officer · sold 9,741 at avg $0.545K2.9% of stake
- Mar 5, 2025Column Group Iii, LPLarge holder · bought 35,714,284 at $0.70$25M263% of stake
- Mar 5, 2025David V GoeddelDirector · bought 35,714,284 at $0.70$25M263% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with TNYA
Held by ETFs
TNYA is in 3 US ETFs. The largest of them, with TNYA's weight in each:
Spot a number that looks wrong? Check it in TNYA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing TNYA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.